Navigation path

Additional tools

  • Print version
  • Decrease text
  • Increase text
  • Choose high contrast version
  • Choose standard colour version




Profile of registrant

Baxter Healthcare SA

Identification number in the register: 84050217165-45
Registration date: 16/11/11 14:31:48

The information on this organisation was last modified on 25/11/14 11:31:42
The date of the last annual update was 17/11/14 09:29:01


Registrant : Organisation or self-employed individual

Name/company name: Baxter Healthcare SA
Acronym: Baxter
Legal status: Corporation
Website address: http://www.baxter.com

Sections

Section: II - In-house lobbyists and trade/professional associations
and more precisely: Companies & groups

Person with legal responsibility

Surname, Name: Mr  Pierre Destexhe
Position: Associate General Counsel

Permanent person in charge of EU relations

Surname, Name: Mr  Toon Digneffe
Position: Director Government Affairs and Public Policy, European Affairs

Contact details:

Contact details of organisation's head office: 130 Thurgauerstrasse Glattpark
Zurich 8152
SWITZERLAND
Telephone number: (+41) 448786000
Fax number: (+41) 448786350
Other contact information: Baxter Brussels office to the European Union:
Baxter World Trade sprl
Alliance Park
Boulevard d'Angleterre 2-4
1420 Braine l'Alleud

Goals / remit

Goals / remit of the organisation: Description:
Baxter manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide.
Baxter employs about 47,600 employees.
One of Baxter's competitive strengths is its diverse technological expertise and commitment to scientific innovation. The company's unique combination of capabilities in medical devices, pharmaceuticals and biotechnology, including specialty biologics, sets it apart from other companies in the healthcare industry.
Goals:
• Baxter interacts with the EU Institutions on the legislation which has an impact on the healthcare industry through its participation in debates and public consultations
• Ensure equal access to treatment and innovative medicines to patients
• Apply innovative science to develop specialty therapeutics and medical products that save and sustain patients’ lives
• Improve conditions for prevention, treatment and care to address unmet needs
• Raise awareness and support the voice of patients suffering from chronic and life threatening diseases
• Support policy development aiming at improving regulatory processes for the healthcare sector and the competitiveness of research and industry
The organisation's fields of interests are:
  • global

Number of persons engaged in activities falling under the scope of the Transparency Register

Number of persons: 4
Complementary information: the 4 persons are
Toon Digneffe
Frederik Ulrichs
Astrid Jankowitsch
Maria Rodriguez Sanchez

Persons accredited for access to European Parliament premises

First name Surname Start Date End Date
Maria RODRIGUEZ SANCHEZ 11/02/14 10/02/15
Toon DIGNEFFE 11/02/14 10/02/15
Frederik ULRICHS 25/02/14 21/02/15

Activities

Main EU initiatives covered the year before by activities falling under the scope of the Transparency Register:


Legislative initiatives and policy issues in the field of healthcare policy and patient access.

Fields of interest for e-mail alerts on consultations and roadmaps;

Fields declared by the organisation:
  • Competition
  • Consumer Affairs
  • Economic and Financial Affairs
  • Energy
  • Enterprise
  • Environment
  • Information Society
  • Public Health
  • Research and Technology
  • Taxation

Networking

Information on (i) organisation's membership of any associations/federations/confederations or (ii) relationships to other bodies in formal or informal networks.




EFPIA, Eucomed, EBE, Europabio, PPTA, Amcham EU

Financial data

Financial year: 01/2013 - 12/2013
Estimated costs to the organisation directly related to representing interests to EU institutions in that year: 200000  € - 250000  €
Amount and source of funding received from the EU institutions in financial year n-1 of registration
Procurement: 0 €
Grants: 0 €
Other (financial) information provided by the organisation:


Code of conduct

By its registration the organisation has signed the Transparency Register Code of Conduct.